Months after cancer drug trial, Merus agrees to be bought at 41% premium

1 week ago 7
ARTICLE AD BOX
Merus agreed to be bought for a 41% premium, months after a positive trial of a cancer drug.
Read Entire Article
  1. Homepage
  2. Finance
  3. Months after cancer drug trial, Merus agrees to be bought at 41% premium

Related

Jobless claims — and layoffs — are still low. Unofficially, that is.

Jobless claims — and layoffs — are still low. Unofficially, ...

40 minutes ago 0
Private equity and private credit may fit your 401(k) retirement plan — but here’s what you need to know

Private equity and private credit may fit your 401(k) retire...

48 minutes ago 0
Inside Intel's Hail Mary to Reclaim Chip Dominance

Inside Intel's Hail Mary to Reclaim Chip Dominance

1 hour ago 0

Trending

Popular

Can Pidcock win big & why did it end at Ineos?

Can Pidcock win big & why did it end at Ineos?

7 months ago 326
Netflix scuttles plans to add six previously announced games to its service

Netflix scuttles plans to add six previously announced games...

8 months ago 314
OpenAI co-founder John Schulman has left Anthropic after less than a year

OpenAI co-founder John Schulman has left Anthropic after les...

8 months ago 274
Steam will label early access games that haven't been updated in a year

Steam will label early access games that haven't been update...

8 months ago 274
‘I didn’t want to spend time with my children. I was just going through the motions’: the pain of parental burnout

‘I didn’t want to spend time with my children. I was just go...

7 months ago 269
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Nexa News 2025. All rights are reserved